Results 31 to 40 of about 48,625 (267)
Long-term treatment with bisphosphonates and their safety in postmenopausal osteoporosis
, 2010 Bisphosphonates are the leading drugs for the treatment of osteoporosis. In randomized controlled trials (RCTs), alendronate, risedronate, and zoledronate have shown to reduce the risk of vertebral, nonvertebral, and hip fractures, whereas RCTs with ...
Graham Russell +8 more
core +1 more source
Frontiers in Pharmacology, 2023 Osteoporosis and periodontitis are two major chronic diseases of postmenopausal women. The association between these two diseases are evident through systemic bone loss and alveolar bone loss.
Putri Ayu Jayusman +5 more
doaj +1 more source
Journal of Family Medicine and Primary Care, 2019 Objectives: Osteoporosis continues to be underrecognized in many parts of India. This study was undertaken to assess the level of knowledge of osteoporosis among postmenopausal women referred for a dual-energy X-ray absorptiometry (DXA) scan in a ...
Manickavasagam Senthilraja +5 more
doaj +1 more source
The Impact of Vertebral Fractures on Quality of Life in Postmenopausal Osteoporosis
, 2011 Aim: The aim of this study was to investigate the impact of vertebral fractures on quality of life in postmenopausal osteoporosis. Material and Methods: 158 postmenopausal women were included in this study.
Hakan Nur, N. Füsun Toraman
core +1 more source
Similarities in Acquired Factors Related to Postmenopausal Osteoporosis and Sarcopenia
Journal of Osteoporosis, 2011 Postmenopausal population is at increased risk of musculoskeletal impairments. Sarcopenia and osteoporosis are associated with significant morbidity and social and health-care costs.
Joonas Sirola, Heikki Kröger
doaj +1 more source
Advanced Science, EarlyView.Osteosarcoma is the most common primary bone tumor with limited treatment options and a terrible prognosis. This review provides a comprehensive summary of the recent development of osteoimmunomodulatory implants for post‐operative osteosarcoma treatment, of which the potential utility in evoking durable anti‐osteosarcoma immunity and accelerating bone
Yilong Dong +6 more
wiley +1 more source
Risk factors for osteoporosis in South Asian and Caucasian postmenopausal women [PDF]
, 2011 There is evidence to show that the risk of osteoporosis is greater for South Asian females compared to Caucasian females. This is due to differences in bone mineral density and other risk factors which contribute to this condition such as calcium and ...
Gifford, Heather
core
The prevalence and treatment rate trends of osteoporosis in postmenopausal women.
PLoS ONE, 2023 BackgroundTo evaluate the prevalence and treatment of postmenopausal women with osteoporosis in recent years, analyze differences between the prevalence diagnosed by physicians and the prevalence detected by bone mineral density (BMD), and observe the ...
Xiaojuan Zhang +6 more
doaj +1 more source
Amuc_1473 Links Gut Microbes to Skeletal Homeostasis and Counteracts Multifactorial Osteoporosis
Advanced Science, EarlyView.Amuc_1473, a previously uncharacterized protein enriched in Akkermansia muciniphila‐derived extracellular vesicles, is identified as a gut–bone messenger that promotes osteogenesis and inhibits osteoclastogenesis by engaging transcriptional and translational regulators in bone cells.
Shan‐Shan Rao +28 more
wiley +1 more source
Animal Models and Experimental Medicine, EarlyView.Transcutaneous electrical nerve stimulation (TENS) improved knee osteoarthritis (KOA) in rats by regulating interleukin‐1β (IL‐1β), IL‐6, and IL‐8 expressions and the bone morphogenetic protein 2 (BMP‐2)/transforming growth factor β (TGF‐β) signaling pathway.
Yan Sun +6 more
wiley +1 more source